As of 4:00pm ET
| +0.71 / +2.84%|
The 7 analysts offering 12-month price forecasts for Healthways Inc have a median target of 26.00, with a high estimate of 29.00 and a low estimate of 12.00. The median estimate represents a +1.17% increase from the last price of 25.70.
The current consensus among 8 polled investment analysts is to Buy stock in Healthways Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.